3-iodobenzylguanidine has been researched along with Mitral Valve Stenosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, H; Ashihara, T; Fukuyama, T; Imamura, Y | 1 |
| Fukuyama, T; Imamura, Y | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Mitral Valve Stenosis
| Article | Year |
|---|---|
Myocardial adrenergic nervous activity is intensified in patients with heart failure without left ventricular volume or pressure overload.
Topics: 3-Iodobenzylguanidine; Atrial Natriuretic Factor; Cardiac Catheterization; Cardiac Output; Case-Control Studies; Contrast Media; Echocardiography, Doppler; Female; Heart; Heart Failure; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Stenosis; Norepinephrine; Radionuclide Imaging; Sympathetic Nervous System; Time Factors; Ventricular Function, Left; Ventricular Pressure | 1996 |
[Myocardial adrenergic nerve activity in valvular diseases assessed by iodine-123-metaiodobenzylguanidine myocardial scintigraphy].
Topics: 3-Iodobenzylguanidine; Aged; Contrast Media; Echocardiography; Female; Heart; Heart Failure; Heart Valve Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitral Valve Stenosis; Radionuclide Imaging; Sympathetic Nervous System | 1997 |